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1INTRODUCTION
2Idiopathic intracranial hypertension (IIH) is the clinical syndrome of
elevated intracranial pressure, without hydrocephalus or mass lesions and
with normal cerebrospinal fluid (CSF) composition.  The  condition has
been known to exist for over a hundred years and has been described by
various names including the previously popular pseudo tumour cerebri
and benign intracranial hypertension, the variation in nomenclature
reflecting the continuing uncertainty about the  precise nature of the
condition as also the variations in the ideas of origin, diagnostic and
treatment methods.
The precise underlying mechanism of increased CSF pressure and which
intracranial compartment is primarily involved in the absence of
ventricular dilatation resulting in IIH is still unclear. Several theories for
IIH  pathophysiology have been put forth based on neuroimaging and
CSF hydrodynamic studies. These include  obstruction or resistance to
CSF outflow at the level of the arachnoid granulations, increased rate of
CSF formation and alteration in the elasticity of the brain parenchyma
and intracranial blood vessels, obstruction to venous outflow at the level
of the superior sagittal sinus, and reduction in the capacity of the cranial
and spinal subarachnoid space to expand.
3There is ample evidence from infusion and perfusion studies that IIH is
associated with an impairment of outflow of CSF, i.e. defective
absorption, hence the role of CSF dynamics studies in diagnosis, and
possibly in exercise of management options and follow up.
This  study  analyses  the  role  of  resistance  to  outflow  of  CSF  (Rout)
measurement obtained by CSF dynamics study in the diagnosis of IIH,
employing the simple bedside saline manometry and improvised bolus
injection method [The Madras Institute of Neurology (MIN) method].
4AIM OF THE STUDY
5? To measure the resistance to outflow of CSF (Rout) , the opening
pressure (Po) and the pressure-volume index (PVI) in patients with
Idiopathic Intracranial Hypertension (IIH)  by bolus lumbar
injection method.
? To evaluate the usefulness of cerebrospinal fluid outflow resistance
(Rout)  measurement in the diagnosis of  Idiopathic Intracranial
Hypertension (IIH).
? To compare the value of cerebrospinal  fluid outflow resistance
(Rout) measurement with opening pressure (Po) measurement in the
diagnosis of  Idiopathic  Intracranial  Hypertension(IIH).
6REVIEW OF LITERATURE
7Literature review is done under the following headings:
1. Historical background
2. Diagnostic criteria
3. CSF physiology
4. Pathogenesis and altered CSF dynamics
5. Methods to assess  changes in CSF dynamics
1. HISTORICAL BACKGROUND
The German physician Heinrich Quincke (1893) published  the first
description of the condition, calling it ‘meningitis serosa’1. This appeared
to be preceded by case reports describing the same condition as early as
1866 by Bouchat (reported by Passot2, 1913) who, introduced the
‘pseudo’ concept, speaking of ‘pseudo-meningitis’. A second German
neurologist, Max Nonne, (1904) identified cases of apparent cerebral
tumour  whose subsequent clinical course appeared to preclude a
diagnosis of tumour, coining the  term ‘pseudotumour cerebri’3 . From
1931 onwards, an English neurologist, Sir Charles  Symonds, wrote a
series of papers describing children who had elevated intracranial
pressure  in association with middle ear disease, which he called ‘otitic
hydrocephalus’, suggesting that  the raised pressure was a result of excess
cerebrospinal fluid (CSF)4,5,6.
8By the turn of the 20th century, the terms serous meningitis and
pseudotumour cerebri had been adopted, but diagnosis relied on clinical
features or postmortem findings. Cerebral pneumography permitted
further study of the condition in live patients and this was later to be
enhanced by ventriculography and encephalography. Around this time
Davidoff and Dyke (1956) published a report of 15 cases with normal
cerebral pneumography, all of whom improved with cranial
decompression7.
In 1937, the American neurosurgeon Walter Dandy  described 22 cases of
‘intracranial pressure without brain tumour’ and is credited with the first
diagnostic criteria for the condition8.
Foley (1955) published a detailed study dividing cases of the condition
into those associated with ear disease and those with no known cause of
raised intracranial pressure9. He regarded hydrocephalus as an
inappropriate term, since the cerebral ventricles were not enlarged and
introduced the name ‘benign intracranial hypertension’ for non-otitic
cases. He described amongst this cohort  of predominantly female, young,
overweight patients “a variety of proposed  aetiological agents so
numerous and diverse that one must suspect that none is a  direct cause.”
The term benign intracranial hypertension was used for many years until
9several reports of severe visual loss in the condition rendered the  term
‘benign’ inappropriate.
Corbett and Thompson(1989) suggested the term  “Idiopathic Intracranial
Hypertension” as the previous terms do not adequately describe the
disorder and emphasize the severity of the condition, though it is to be
noted that Buchheit et al had in 1969 itself proposed the term “Idiopathic
Intracranial Hypertension”10,11 .The late 1970s and early 1980s saw
papers  on mechanism by Johnston (1973,  1975), Fishman (1979, 1984),
Rottenberg et al. (1980) and Donaldson (1981).  The  consensus favoured
a primary disorder of CSF dynamics, with the creation  of  an imbalance
between formation and absorption resulting in an increase in  CSF
volume. Reid et al. (1980, 1981) favoured  brain oedema based on
Computerized Tomogram(CT) evidence of ventricular size, Sugerman et
al. (1995, 1999) implied causative role for obesity, and King et al. (1995)
and Karahalios et al. (1996) suggested a much expanded causative role
for increased cranial venous outflow pressure12,13. Idiopathic intracranial
hypertension remains quite perplexing and fascinating, despite a century
or more of investigation and study.
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2. DIAGNOSTIC CRITERIA
Dandy criteria:
In his original paper, Dandy (1937) describes in detail the clinical
features of the condition in  22 cases, but does not actually list the
diagnostic criteria. The first specific listing of  the ‘modified Dandy
criteria’ was that by Smith in 1985,  his list being as follows14 :
1. Signs and symptoms of increased intracranial pressure (headaches,
nausea, vomiting, transient obscurations of vision, papilloedema).
2. No localizing neurological signs otherwise, with the single
exception being  unilateral or  bilateral  abducens  nerve paresis.
3. Cerebrospinal fluid which can show increased pressure but with no
cytological or chemical abnormalities otherwise.
4. Normal to small symmetrical ventricles must be demonstrated
(originally required ventriculography, but now demonstrated by
computed tomography).
These ‘modified’ criteria have themselves been modified in subsequent
papers.
Radhakrishnan et al. (1994) have listed the following criteria for the
diagnosis of  IIH15 :
1. Signs and symptoms of increased intracranial pressure.
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2. No localizing neurological signs, in an awake and alert patient,
other than  abducens nerve paresis.
3. Normal neuroimaging except for small ventricles or an empty sella.
4. Documented increased pressure (250mm of water or more) but a
normal composition of the cerebrospinal fluid.
5. Primary structural or systemic causes of elevated intracranial
venous sinus pressure excluded (for example, sinovenous
thrombosis, hyperviscosity syndromes, and right heart failure).
Other studies on this issue include those of Ahlskog and O’Neill (1982),
Corbett(1983) and  Carlow et al. (1987).
In  their  recent  review,  Sussman  et  al.  (1998)  added   a  sixth  criterion  :
“benign clinical course apart from visual deterioration” 16.
Friedman and Jacobson in 2002 updated diagnostic criteria for IIH for
purposes of routine patient management and for clinical trials and the
following is their “Criteria for diagnosing idiopathic intracranial
hypertension” 17.
1. If symptoms present, they may only reflect those of generalized
intracranial  hypertension  or  papilledema.
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2. If signs present, they may only reflect those of generalized
intracranial hypertension or papilledema.
3. Documented elevated intracranial pressure measured in the lateral
decubitus position.
4. Normal CSF composition.
5. No evidence of hydrocephalus, mass, structural, or vascular lesion
on magnetic resonance imaging (MRI) or contrast-enhanced CT for
typical patients and MRI and MR venography for  all others.
6. No other cause of intracranial hypertension identified.
A complete list, covering all the criteria included in the different studies,
might read as follows:
1. Signs and symptoms of raised intracranial pressure.
2. Absence of focal neurological signs.
3. Measured increase in CSF pressure.
4. CSF of normal composition.
5. Normal  imaging  studies  (including  MRI  /  MRV)  apart  from
possibly small   ventricles and an empty sella.
6. Not attributable to another cause.
7. Benign clinical course apart from possible adverse effects of raised
CSF pressure on the optic nerves.
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This last is a slightly expanded version of the recent list offered by
Friedman and Jacobson (2004).
The criteria as currently formulated in the International Headache Society’s (IHS)
classification of  headache disorders (2nd edition)  are outlined below18:
1. Alert patient with neurological examination that either is normal or
demonstrates any of  the following abnormalities:
a. Papilloedema
b. Enlarged blind spot
c. Visual field defect
d. Sixth nerve palsy
2. Increased CSF pressure ( >200 mmH2O in the non-obese, >250
mmH2O in  the obese) measured by lumbar puncture in the
recumbent position or by epidural or  intraventricular  pressure
monitoring.
3. Normal  CSF  chemistry  (low  CSF  protein  is  acceptable)  and
cellularity.
4. Intracranial disease (including venous sinus thrombosis) ruled out
by  appropriate  investigation.
5. No metabolic, toxic or hormonal cause of intracranial
hypertension.
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A presenting headache is attributed to idiopathic intracranial hypertension
when the headache develops in close temporal relation to the increased
intracranial pressure and improves after withdrawal of CSF. The
headache should be progressive with at least one of the following:
a) Daily occurrence
b) Diffuse and/or constant non-pulsating pain
c) Aggravated by coughing or straining
3.  CSF PHYSIOLOGY
CSF is physiologically produced by active secretion from cerebral arterial
blood.  The  major  site  of  this  process  is  the  choroid  plexuses  of  the
ventricular system, but the  extrachoroidal production of CSF is
responsible for a significant amount of the total CSF  formation.CSF
production rate can be assessed by means of continuous CSF drainage
techniques or perfusing the subarachnoid spaces with a tracer and
subsequently measuring its dilution19.Unfortunately, both  techniques
have the limitation of averaging all possible dynamic components of
CSF production. Therefore, although the normal average rate of CSF
production  in human beings is accepted to be 0.35 ml /min, very little is
known about  dynamic changes in its production rate and their clinical
significance. CSF secretion is supposed to be proportional to brain
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metabolism and tends to  decrease with age.CSF flows from the lateral
and third ventricles through the  aqueduct of Sylvius to reach the fourth
ventricle. Passage through the narrow  aqueduct is pulsatile, and its flow
velocity can be detected by phase-contrast MRI techniques. The study of
the  characteristics  of  CSF  pulsations  is  promising  and  several  MRI
techniques have gained increasing interest for the modelling and the
diagnosis of CSF dynamics disturbances.
Normally, CSF exits the fourth ventricle through the foramina of
Magendie and Luschka, flows freely through the basal cisterns upwards
towards the superior sagittal sinus and downwards towards the lumbar
subarachnoid space. The spinal subarachnoid space accounts for a
significant  part  of  the  compensatory  reserve  of  the  system,  with  a
compliant venous network that can accommodate acute changes in
intracranial volumes displacing CSF caudally. This volume-buffering
mechanism is based on the free circulation of CSF fluid cancelling out all
intracranial pressure (ICP) gradients and therefore protecting the brain
from the risk of herniation. If the normal pathways of CSF circulation are
viable such as in the case of communicating forms of hydrocephalus
patients can tolerate acute rises in ICP up to 60mmHg without any
subsequent adverse effect.
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Re-absorption of CSF fluid into the venous compartment takes place
predominantly through the arachnoid granulations of the sagittal sinus.
The resistance to CSF outflow has been assessed in normal subjects as
ranging from 6 to 10mmHg/ml/ min20.In  cases  of  disturbed  CSF  re-
absorption through the physiological pathways, a secondary component
of CSF re-absorption is the leakage directly into the brain parenchyma.
This phenomenon can sometimes be visualized as a periventricular hypo-
density along the horns of the lateral ventricles21.
4. PATHOGENESIS AND ALTERED CSF DYNAMICS:
The pathogenesis of raised ICP in IIH remains unclear. IIH has become a
‘disease of Theories’ because of the many postulated hypotheses that
have been put forward to explain  its pathogenesis. No single theory has
been able to provide a comprehensive answer and so there remains little
consensus as to its cause. According to the Monro-Kellie rule, anything
added to the blood, CSF, or brain volume or anything impeding CSF or
venous egress would be expected to increase ICP.
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The causes which could increase the intracranial pressure are as follows:
Increased cerebral volume
increased interstitial fluid (ISF)
volume
increased blood volume
increased tissue volume
Increased CSF production rate
Increased CSF outflow resistance
Increased cerebral arterial pressure
transmitted to capillaries (loss of
auto regulation)
Increased cerebral venous pressure
leading to increased venous blood
volume  and increased ISF volume
leading to reduced CSF outflow
CT Scan offered a way of assessing cerebral volume in IIH, albeit
somewhat  crudely. A reduction in the size of the ventricular system,
indicating an increase in cerebral volume, was reported in some
studies22,23.24, but not in others25,   and  it  remains  controversial  as  to
whether cerebral volume is significantly increased in IIH. The
disagreement perhaps reflects heterogeneity of pathogenesis. The hope
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has been expressed that MRI will provide a great deal more information
about what is going on in IIH, but thus far there has not been an
abundance of reported studies of cerebral and CSF volumes in IIH, nor of
the composition of cerebral tissue. Moser et al26 reported an increase in
white matter water signal, suggesting diffuse mild oedema, and Gideon et
al27  detected increased water mobility in subcortical white matter.
Both studies required the use of special MRI sequences, routine
sequences showing no abnormality. The brain in IIH has also been
studied by positron emission tomography. Notably, no change in regional
cerebral blood volume was found28. The most invasive studies of cerebral
tissue in IIH were cerebral biopsies, which were reported by Sahs and
Joynt to show evidence of interstitial cerebral oedema, but necropsies
have not confirmed those findings, nor did a review of some of the
original biopsy material of Sahs and Joynt29,30.
Increased CSF production
Increased CSF production rate has been proposed as a mechanism of IIH.
The production rate of CSF can be measured in patients, but the
procedures (infusion or perfusion techniques) are invasive. In one study
increased CSF production rate was reported in IIH31. However, most
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investigators have not found CSF hyper secretion in IIH. An attempt at
measuring CSF production rate noninvasively by recording CSF flow
through the cerebral aqueduct using MRI did not support the view that
CSF hyper secretion is important in IIH32.
The only condition in which the CSF production rate is known definitely
to be increased is choroid plexus papilloma, a fairly rare paediatric
tumour. An IIH-like syndrome has not been reported in choroid plexus
papilloma. Idiopathic intracranial hypertension would require a
generalised increase in intracranial pressure without a significant pressure
gradient across the cortical mantle, and without any capacity for the brain
to be compressed. Mathematical modelling of ventricular size in the
circumstance of increased CSF production predicts hydrocephalus, not
IIH33. Experimental infusion of artificial CSF into the  lateral ventricles
of dogs leads to modest ventricular enlargement, not an IIH- like
syndrome34.
CSF outflow obstruction
Much more important and relevant is the likelihood that impaired outflow
of  CSF  into  the   venous  system  is  a  cause  of  IIH.  An  increase  in  CSF
pressure, either due to CSF overproduction or due to impaired absorption,
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would be expected to lead to an increase in CSF volume, if the CSF space
had the capacity for any expansion. Within a non-expansile skull and
relatively non-expansile spinal canal, CSF could only easily accumulate
at the expense of cerebral blood volume. In IIH there is neither a
reduction in cerebral blood volume, nor an increase in CSF volume. If the
proposition  is  that  the  impairment  of  outflow of   CSF is  a  lesion  at  the
arachnoid villi and granulations level, then there is no reason to expect
any trans mantle pressure gradient, and it is easier to envisage this as a
mechanism for IIH than Normal Pressure Hydrocephalus. Infants might
represent a special case, as a non-acute increase in intracranial pressure
may be expected to cause expansion of the skull vault, allowing the
accumulation of CSF, either inside the ventricles or outside (external
hydrocephalus). However, in the mathematical model of Rekate et al, an
increase in CSF outflow resistance alone leads to hydrocephalus,  and  to
generate the conditions found in IIH a reduction in brain compressibility
is required as well33.
There is ample evidence from infusion and perfusion studies that IIH is
associated with an impairment of outflow of CSF. There is no direct
evidence of dysfunction of arachnoid villi and granulations in IIH.
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Abnormalities of arachnoid villi have, however, been noted in certain
conditions which involve raised intracranial pressure.
Microscopy after subarachnoid haemorrhage has disclosed apparent
obstruction of villi by cells and morphological changes in arachnoid villi
and granulations35.
The outflow resistance of CSF is known to be increased in experimental
subarachnoid haemorrhage36.  But  the  disturbance  of  CSF  dynamics
associated with subarachnoid haemorrhage is hydrocephalus, and the
relevant site of CSF flow disturbance might be proximal to arachnoid villi
and granulations.
Intracranial venous hypertension
The final mechanism for IIH is the obvious one of an increase in  venous
sinus pressure - obvious because lesions which increase venous sinus
pressure (for example, dural arteriovenous malformations) or impede
venous drainage (for example, venous sinus thrombosis, malignant
obstruction of  venous sinuses or jugular veins) are known to give rise to
the same syndrome as  IIH. Clearly superior sagittal sinus thrombosis will
affect cerebral venous pressure and drainage and will also directly affect
22
CSF absorption, but any disorder causing a rise in venous pressure will
secondarily have an effect on CSF absorption.
In the CT era it is in fact quite likely that cases of cerebral venous sinus
thrombosis were misdiagnosed as having IIH, as the diagnosis was often
made on the basis of the clinical picture, an unremarkable scan and a
lumbar puncture.
Magnetic resonance imaging and magnetic resonance venography have
improved the reliability of non-invasive detection of cerebral venous
sinus thrombosis, but still some cases may be missed without catheter
angiography or venography37. Recent reports of potentially prothrombotic
abnormalities of coagulation in IIH may be construed as indicating that
undetected cerebral venous sinus thrombosis remains a mechanism of
IIH, although other interpretations are possible38.
Some authors have suggested impaired CSF absorption due to resistance
generated by raised venous pressure from venous outflow obstruction as a
possible  explanation  .  There  is  also  considerable  evidence  that  the
majority of patients with IIH carry a stenosis in the transverse
sinuses(TS), although there is debate on whether such a stenosis   is  a
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cause or effect of the condition as some authors suggest such narrowing
to be secondary to the raised ICP. Higgins et al. investigated 20 patients
with  IIH  and  40  controls  with  MRV.  They  identified  bilateral  TS  flow
defects in 13 of 20 patients with IIH and in none of the 40 controls 39. In a
study by Bono et al., 14 patients with IIH who had bilateral  TS stenoses
were followed over a period of  6 years40. All patients had repeated  MRV
followed by lumbar punctures. Although, CSF pressure normalized in
nine of the 14 patients during the follow-up period with medical
treatment, TS stenosis persisted in all patients suggesting that TS defects
may not be  secondary to raised CSF pressure.
King  et  al   reported  briefly  on  a  larger  patient  series.  Fifteen  out  of  17
patients with IIH had raised superior sagittal sinus and proximal
transverse sinus pressures with a drop in pressure in the distal transverse
sinus.  In  four  of  these  patients  CSF  was  removed  at  the  time  of
manometry with a resultant lowering of intracranial pressure, and that led
to abolition of the apparent  functional obstruction of the distal transverse
sinus, which suggested to the authors that intracranial hypertension
caused compression of the transverse sinus in some patients41.
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This study highlights the possibility that increases in CSF pressure and
venous pressure can interact so that each makes the other worse. The
authors imply that they do not consider the increase in venous sinus
pressure to be the primary event in most of their patients. By  contrast,
Karahalios et al speculated that “most if not all aetiologies (of IIH) result
in an increase in intracranial venous pressure as a final common
pathway.” In their series, venous outflow obstruction was detected by
venography in five out of 10 patients studied. In the remaining five there
was no obstruction but venous pressures were nevertheless increased, as
were right atrial pressures with transmission of the raised central venous
pressures back to the intracranial venous system. Karahalios et al  discuss
ways in which obesity might lead to raised central venous pressures, but
conclude that the mechanism of increased central venous pressure in IIH
remains obscure42.
Obesity and IIH
The relation between IIH and obesity has long been recognised. Pressure
in the CSF is higher in obese but otherwise normal compared to people of
normal weight. An association between recent weight gain and the
development of IIH has been established. Weight reduction  and bariatric
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surgery  has  long  been  part  of  the  treatment  strategy.  There  is  some
evidence that weight reduction is therapeutic43.
The concept of  Secondary IIH
Although considered to be idiopathic, detailed investigation may reveal
venous outflow abnormalities in IIH patients. This had led to a distinction
in terminology with “secondary IIH” commonly being attributed to
conditions causing increased dural sinus pressures. Guiseffi et al
proposed a criteria for assessing disease association  in IIH, considering
the need to identify the many conditions associated with it44.
Criteria for assessing Secondary IIH45
A Meets Dandy’s criteria
B The condition should be proven to increase ICP
C Treatment of the condition should improve the IIH
D
Properly controlled studies should show an association
between the condition and IIH
The Digre’s scale attempts to rank the probable association between
various conditions and IIH based on the above46 :
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DIGRE’ SCALE
Proven
association
meets 4
criteria Obesity
Likely association meets 3criteria
Drugs: Kerprone, lindane
Hypervitaminosis A
Probable
association
meets 2
criteria
Steroid withdrawal
Thyroid replacement in Children
Hypoparathyroidism
Addison’s disease
Uremia
Iron deficiency anaemia
Drugs: tetracyclines, nalidixic
acid,danazol, lithium, phenytoin,
amiodarone, Nitrofurantoin,
ciprofloxacin, nitroglycerin.
Possible
association
meets 1
criterion
Menstrual irregularity, OCP   use,
Cushing syndrome,Vitamin A
deficiency, Minor head trauma,
Behcet syndrome.
Unlikely
association
meets no
criteria
Hyperthyroidism,steroid use,
Immunisation.
Unsupported association Pregnancy, menarche.
Additional conditions that are not included in Digre’s list but meet
minimal criteria include:
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1) Other drugs : isoretinoin, trimethprim-sulphamethoxazole,
cimetidine and  tamoxifen.
2) Systemic lupus erythematosus.
These are all considered treatable causal factors for IIH.
5.   METHODS TO ASSESS CSF DYNAMICS; Rout MEASUREMENT:
The balance between CSF formation and absorption in holding the Intra
Cranial Pressure(ICP) constant is given by the Davson equation47
ICP = Fr .Rout  +  Pss  =  Er.Rout  +  Pss
Where, Fr is CSF formation rate ; Rout is the resistance to CSF outflow ;
Pss is the pressure in the sagittal sinus ; Er is the CSF elimination rate.
Based on an average volume of 150ml, the turnover of  CSF is 14% per
hour.
Borgesen and Gjerris (1987) , based on study on 333 patients, related the
formation rate and ICP as follows:
ICP = 3.0 + 0.3.Rout
 They indicate that the normal production rate of CSF is 0.3ml/min48.ICP
is normally maintained by the resistance factor of CSF outflow, as given
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by the Davson equation above. Regulation of CSF volume by means of
outflow resistant factors, especially the venous part, is probably the major
mechanism of protection of  brain against lethal increases of  ICP.
Human beings have the highest overall rate of CSF formation, the
greatest efflux capacity and the lowest outflow resistance. A CSF outflow
can sustain efflux rates of  atleast 2.0ml/min21.
Marmarou et al.(1978)  introduced the PVI (Pressure Volume Index)
reflecting the correlation between an increasing volume and the resulting
pressure.
They measured the response of CSF pressure to a bolus injection and
showed how to calculate both compliance and resistance to CSF flow.
The  PVI  is given by the slope of the volume - log  pressure curve. Rout
measured by this method is given by the formula :
R out  =
Where - P0 is opening pressure
- Pp is the peak pressure
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- P2 is the instantaneous pressure at time t2 on the recovery slope
- t2 is the elapsed time from the instant of  injection to the point at
  which P2 is determined
Measurement of  Resistance to CSF outflow ( Rout) :
 The  aim  is  to  measure  the  outflow  rate  of  CSF  from  the  CSF
compartment.
The three methods in clinical practice are
1) Infusion tests
2) Bolus injections, and
3) Isotope dilution methods.
1) INFUSION TESTS :
These methods monitor ICP during infusion of synthetic CSF or Ringer’s
lactate. They are based on principle of  injecting, infusing or perfusing
artificial CSF intrathecally at either a constant rate or constant pressure
and  plotting  the  flow  (ml/min)  against  ICP  levels.  The  slope  of  the
regression curve is an expression of conductance to CSF outflow (Cout) ,
and the reciprocal value is resistance to outflow (Rout = 1/Cout).
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The  calculation  of   Rout implies  a  constant  rate  of  CSF  production,  and
constant CSF and blood volumes, irrespective of the increases in ICP
during the study. All methods give a possibility of CSF leak, which will
result in too low Rout values. Three techniques have been described on
this principle:
1. constant pressure servo controlled infusion method :– though more
accurate, is time consuming and difficult.
2. constant infusion method: (Katzman test51): -- easy and not very
time consuming, but the interpretation of plateauing of the induced
pressure rises is difficult. Czosnyka  et al. devised the
computerised infusion test for measuring the Rout and  other   CSF
parameters, and is simple, quick and less invasive52.
3. constant infusion and constant pressure method: (lumbo ventricular
perfusion  method)  –gives  reliable  results,  but  there  is  risk  of
infection.
2)  BOLUS INJECTION TESTS :
The bolus technique is fast and simple, but is based on complex
mathematical calculations. It is based on the first mathematical model of
CSF pressure-volume which provides much of the basis for
understanding the CSF dynamics, devised by  Marmarou and verified
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experimentally in his work. Using this model, the author described the
pressure-volume index (PVI) as the volume required to increase ICP
tenfold,  in  other  words,  as  the  compliance  or  the  ability  of  the
craniospinal system to accommodate the change in volume per unit
change in pressure (dV/dP) over the whole physiological range of ICP.
Marmarou’s model also allowed the identification of CSF outflow
resistance (Rout) which is considered to be the impedance of flow offered
by the CSF absorption pathways. Absorption of CSF fluid into the venous
compartment takes place predominantly (in humans) through arachnoid
granulations adjacent to the walls of the sagittal sinus. The nature of the
CSF absorption is proportional to the pressure gradient between the CSF
side of  the granulation and the sagittal sinus .
The bolus CSF infusion method used in our clinical study involves
injecting a known volume, usually 5 ml, into the lumbar subarachnoid
space at a rate of 1 ml/s. Recording the baseline pressure just before
injection (P0), the maximum pressure immediately after injection (Pp),
and the pressure after a time (t) from the injection (Pt) determines the Rout
which is calculated from the following equation : Rout =  P0/PVI  x  log
32
[(Pt/Pp) x (Pp - P0)/(Pt - P0)] and the PVI which is also calculated using the
equation: PVI = dv/log (P0/Pp) .
The bolus method seems more valuable in patients with increased ICP (
high elastance/low compliance), that is, in patients with diffuse head
injury and patients with idiopathic intracranial hypertension.
3) RADIO ISOTOPE DILUTION METHODS:
Radioisotope introduced intrathecally may depict production, transport
and resorption of CSF. The tracer is followed by a gamma camera both in
space and time over 1,6,24 hours. The pattern of distribution of CSF flow
as illustrated by radioactive tracer, is not only an expression of  the
degree of obstruction to CSF outflow but also CSF volume.
CSF DYNAMICS STUDIES IN NORMAL SUBJECTS:
In  a study  of   healthy  volunteers using lumbar infusion  method,
Borgeson and Gjerris(1982)  found a mean ICP of  11.1 mmHg  and Rout
of 9.1mmHg/ml/min53.
Normal values of Rout in different studies are as under (mmHg/ml/min)
Ekstedt(1978)50  < 8.33
Sklar et al.(1979)54 < 10.00
Albeck et al(1991)55  <  9.1
Ramesh et al.(2005)56  < 9.6
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The value of Rout increases with age57. Many studies have over a period of
time proved the reproducibility and reliability of repeated Rout
measurements employing more than one method described above.
Rout measurements in individuals with pseudotumour cerebri, the older
term for IIH have shown elevated values in most patients. Many patients
have been found to have normal or only slightly elevated ICP, especially
in the later phase of the disease process.The studies by Gjerris, Calabrese
and Janny  have observed raised Rout in patients with IIH62.
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MATERIALS AND METHODS
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The study was undertaken at The Institute of Neurology, Madras Medical
College and Rajiv Gandhi Government General Hospital, Chennai,
between April 2008  and  February 2011.
The study was conducted on patients admitted in the Neurosurgical wards
with a clinical diagnosis of  Idiopathic Intracranial Hypertension, as
suggested by the ‘Modified Dandy criteria’ .
All patients had headache of varying severity, persistent and constant for
few weeks prior to admission, necessitating medical advice. The temporal
profile of headache was suggestive of raised intracranial pressure in all of
them. All patients had papilloedema clinically ,and  were confirmed by
the Neuro ophthalmologist of the Institute, and visual field charting were
done. None had any focal neurological deficit after a thorough
neurological examination, other than the lateral rectus palsy in a few.
None had history of chronic medications. All patients had contrast
enhanced CT and MRI Brain and MRV done to rule out venous sinus
thrombosis and there was no evidence of  hydrocephalus, mass or
structural, or vascular  lesions in any of them. All patients were alert and
co-operative.
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The approval of The Institutional Ethics Committee was obtained. All
patients were explained in detail about the procedure and written
informed consent was obtained. The CSF dynamics study was undertaken
in all of them as per the method described below.CSF samples were sent
for analysis and were found to be of normal composition in all.
The method of CSF dynamics study :
The  bolus lumbar injection method advocated by Marmarou  and
improvised at the Institute of Neurology (MIN method) was used56.
The apparatus consists of a saline stand, a one meter scale, an intravenous
set, a three way adaptor, 20 G disposable lumbar puncture needle,
syringes and 2% lignocaine for local anaesthesia.
The scale is mounted on the saline stand and the saline filled intravenous
set is mounted and fixed over the scale as a manometer to allow readings
to be taken directly. The saline column of  the manometer is kept at 11cm
H2O, with the zero level adjusted to correspond to the spine of the patient,
the level of  the spinal needle. The saline filling up to 11cm, representing
the normal intracranial pressure, is done to avoid the loss in pressure head
by the volume of CSF that goes to fill the manometer. After explaining
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the procedure and after obtaining informed written consent, the patient is
positioned in the Right lateral decubitus position and under sterile aseptic
precautions, lumbar puncture is performed with 20 G spinal needle and
the needle is connected to the saline manometer through the 3-way
adaptor without letting out any CSF. The patient is allowed to relax,
extend lower limbs and neck, lying comfortably in Right lateral position,
and the opening pressure, P0 is noted after the saline column stabilises.
A known volume of saline, rV , usually 5ml is injected into the
subarachnoid space at the rate of  1ml/second, through the 3-way port.
The peak pressure, Pp , reached after the bolus injection  is noted. The
saline column falls gradually  after reaching the peak. After a certain
time, t (in minutes), the pressure recording in the manometer , Pt ,  is
noted.
The CSF outflow resistance is calculated by the two step Marmarou’s
formula :
Step 1 :
Calculation of the pressure  - volume index (PVI)
PVI  = rV/log (Pp /Po)
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Step 2 :
Calculation of resistance to outflow of CSF (Rout)
R out  =    cmH2O/ml/min.
This value is divided by 1.36 to express in mmHg/ml/min. About 25 to 30
ml of therapeutic drainage of  CSF was done in each case. The procedure
was uneventful in all cases, and the patients tolerated well.
The details of the patient and the observations were recorded in a detailed
proforma (vide Appendix 3).
The  P0, PVI   and   Rout were recorded. The value of P0 and  Rout in
establishing the diagnosis of  IIH was studied.
The statistical analysis was done using the software SPSS version 11.5.
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Figure – 1 :  Materials
Figure – 2 : The  Lumbar puncture
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Figure - 3 : The Bolus injection
Figure - 4: The Saline Manometer
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RESULTS
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Forty seven patients with features of IIH  treated during the period
between April 2008 and February 2011were included in the study.
The details of the patients are shown in the table:
S. NO. AGE SEX Opening Pres. R out
1 33 F 31 11.4
2 28 F 21 9.4
3 40 F 18 6.9
4 45 M 37.5 16.9
5 27 F 37 5.8
6 32 F 15 2.8
7 37 F 19 22.6
8 29 F 42 53.4
9 40 F 40 4.3
10 36 M 16 43.7
11 21 F 45 8.1
12 28 M 33 4.7
13 26 F 25 10.3
14 36 F 35 6.6
15 45 M 14 27.1
16 30 F 25 27.8
17 28 M 49 15.1
18 49 M 21 10.9
19 24 M 65 17
20 48 F 38 48.5
21 27 F 42.5 21.4
22 30 F 27 28.5
23 15 F 19.5 14.3
24 19 F 83 38
25 33 F 41 4.1
26 42 F 47 61.2
27 24 F 39 5.1
28 40 F 60 18.3
29 23 M 33 6.9
30 22 F 64 25.1
31 40 F 55 10.1
32 27 F 25 7.3
33 37 F 24 13
34 40 M 26 10.9
35 30 F 23 7.8
36 32 M 19 3.2
37 41 F 60 17.9
38 29 F 41 7.9
39 40 M 38 16.2
40 18 F 26 8.3
41 27 F 35 11.5
42 24 M 40 13.5
43 15 F 21 9.1
44 26 F 35 6.2
45 42 F 18 12.2
46 22 F 26.5 14.9
47 30 F 18 8.9
Table – 1: Opening pressure and Rout values.
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There were 34 females and 13 males, in the age group of 15 to 49 years.
 Age distribution :
Age No
<20 4
20-30 22
30-40 14
40-50 7
Total 47
Figure – 5 : Age Distribution
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Sex distribution :
Gender No
Male 12
Female 35
Total 47
Figure – 6 : Sex Distribution
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The opening pressure ranged from 14  to 83 cmH2O.
The resistance to CSF outflow ranged from 2.8 to 61.2 mmHg/ml/min.
Of  the 47 patients, 31 had raised resistance to CSF outflow. The rest of
the patients had  Rout  in the normal range. (less than 9 mmHg/ml/min ).
Of  the 47 patients, 33 had opening pressure  >25 cmH2O, and 14 patients
had opening pressure between 15 and  24  cmH2O.
Interestingly, 10  out of  the 14 patients with opening pressure less than
25 cmH2O had  raised  Rout values.
21 patients had high values of  both opening pressure and Rout.
Only 4 patients had low  values of  both opening pressure and Rout.
43 patients  had high values of  either opening pressure  or  Rout  or  both.
Of  the 47 patients 12 underwent Lumboperitoneal shunt for diversion of
CSF,  in view of  the visual field defects and improved. Others were on
conservative management with Acetazolamide with or without
Frusemide.
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All patients reported good symptomatic improvement on the day
following the lumbar puncture and patients on conservative treatment
showed gradual, progressive improvement and none reported back with
signs and/or symptoms of worsening.
Figure – 7 : Distribution of  Opening pressure and Rout
combined
R out
Opening pressure
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Statistical analysis :
Statistical analysis was done using the software SPSS 11.5 and tested the
significance of Rout measurement, opening pressure measurement, and
combined as a criterion for the confirmation of  diagnosis of IIH.
Opening  Pressure :
One-Sample Statistics
N Mean Std. Deviation Std. Error Mean
TEST1 47 1.70 .462 .067
One-Sample Test
 Opening Pressure Test Value = 0
t Df Sig. (2-tailed)
25.243 46 .000
Rout  :
One-Sample Statistics
N Mean Std. Deviation Std. Error Mean
TEST2 47 1.66 .479 .070
One-Sample Test
 R-OUT
Test Value = 0
t df Sig. (2-tailed)
23.754 46 .000
Combined opening pressure and Rout :
One-Sample Statistics
N Mean Std. Deviation Std. Error Mean
Combined 47 1.9149 .28206 .04114
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One-Sample Test
Combined Test Value = 0
T df Sig. (2-tailed)
46.543 46 .000
The  p value was less than 0.05 in all the three cases, implying statistical
significance.
It may be noted that  :
? 70%  of  the patients would have their diagnoses confirmed as IIH
as per the existing diagnostic criterion of  > 25 cmH2O for opening
pressure.
? 66%  of the patients would have their diagnoses confirmed as IIH
when resistance to outflow of CSF (Rout) measurements were made
in the CSF dynamics study.
? 71.4%  ( 10 out of 14 ) of the patients not satisfying the criteria for
opening pressure, qualified for a diagnosis of IIH based on  Rout
measurements.
? 91% of the patients (43 of 47 ) had their diagnosis confirmed as
IIH only when  both  were employed as diagnostic criteria.
49
DISCUSSION
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The important pathophysiological mechanism underlying the
development  of   IIH  is  an  alteration  in  the  CSF  dynamics,  leading  to  a
reduction in the outflow of CSF. It is postulated that in this condition,
there is a relative obstruction to CSF absorption across the arachnoid villi
due either to increased resistance within the villi themselves or to an
increase in sagittal sinus pressure altering the pressure differential which
controls  the CSF absorption.  Production of  CSF continues,  possibly at  a
slightly reduced rate, causing an increase in CSF volume. The increase in
intra cranial pressure will restore or increase the gradient across the villi,
thus balancing the increase in sinus pressure or the resistance within the
villi.  The  CSF  absorption  control  system  is,  therefore  reset  with  an
increased CSF volume and an  increased intra cranial pressure secondary
to an impaired absorptive mechanism. With obstruction to CSF flow at
the villi, ventricular dilatation will occur only if the increase in CSF
volume is too great to be contained within the subarachnoid space.CSF
outflow resistance is an objective measure of the degree of CSF
absorption defect.
Among the methods available for measurement of  Rout, the bolus lumbar
injection method advocated by Marmarou and evaluated by Marmarou et
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al. and Kostelijanetz58, is a simple bedside test for quick measurement of
Rout and can be employed in the clinical setting.
The improvised bolus lumbar injection method (the MIN method) further
simplifies the procedure using simple bedside equipment.
A comparison between the bolus injection and the other methods has
been done in experimental and clinical settings by several studies and
most of them found good correlation between the methods, though the
bolus method showed slightly lower values of  Rout   compared to other
methods.
The other methods, namely  constant pressure servo controlled infusion
method, constant infusion method, constant infusion and constant
pressure method and radio isotope dilution methods are more accurate,
but are time consuming, and require expensive and sophisticated
equipment and are more suited for experimental and research purposes.
Many investigators have found increased intracranial pressure in the
initial phase of IIH59. Intracranial Pressure (ICP) may be normal or only
moderately increased in the later phase of  the disease process60,61.
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Gjerris et al found raised  Rout  in the initial phase in most patients with
IIH60.Calabrese et al found Rout to be increased in all patients with IIH62.
Increased Rout  was found in 8 of 10 patients  by Sklar et al, and half of
them were receiving medical treatment.10 out of 12 patients with benign
intracranial tension were found to have higher than normal Rout  values54.
The opening pressure measurement by lumbar puncture has long been the
only tool employed in the diagnosis of IIH, and exists as a diagnostic
criterion from the days of  Walter Dandy.
Johnston and Paterson in their paper on Benign Intracranial Hypertension
have recorded pressure in the lumbar subarachnoid space and
simultaneous ventricular CSF pressure and found that the two
corresponded extremely closely  in all cases, implying the validation of
lumbar puncture as representative of  ICP.
It has also been noted by them that many patients showed long periods
when the pressue remained quite low, or indeed normal, between short
periods of marked intracranial hypertension. They also suggest that  the
diagnosis of  Benign Intracranial Hypertension should be based on
closely observed clinical and investigative criteria to achieve accuracy of
diagnosis59.
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The 14 patients in our study in whom the opening pressure had been
below 25cmH2O, may well  represent  the  above proportion of patients.
The results of our study show encouraging findings in that 71% of the
above category showed raised Rout  values,  making  Rout  estimation
indispensible in the diagnosis of  IIH.
Saadany et al. have suggested the presence  of a low pressure variant of
IIH, without  papilloedema  and with  borderline CSF pressure of  16 to
20 cmH2O63.
They also suggest that although the hallmark of IIH is papilloedema
which  may be bilateral, assymetrical, or even unilateral  yet this
condition may present without papilloedema, and that "normal or
boderline resting" CSF pressure does not exclude the diagnosis in the
presence of suggestive symptoms and signs. It has been observed by
Soler  et  al  that    due  to  the  wide  diurnal  fluctuation  in   CSF  pressure,
establishing an increased pressure is not always  straight forward.  For
this reason, ‘‘normal’’ levels can be recorded in patients with elevated
optic  discs64.
54
CONCLUSIONS
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The conclusions based on our study on 47 patients with Idiopathic
Intracranial Hypertension are:
? The Madras Institute of Neurology (MIN) method of improvised
lumbar bolus injection method of CSF dynamics is validated as
being simple, quick, and able to produce fairly reliable results for
Rout  estimation.
? The  estimation  of   Rout,  the  resistance  to  outflow  of  CSF,  is
valuable and indispensible  part of the diagnosis of IIH, especially
if the patient has low opening pressure.
? Opening pressure measurement, though useful in many cases of
IIH as a confirmatory diagnostic tool, may sometimes give false
negative values and hence has to be combined with Rout
estimations.
? Rout  estimations, combined with Opening pressure measurement, is
a better diagnostic criterion and may be included as an additional
criterion for the diagnosis of  IIH.
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Appendix 3 : Proforma
CSF Dynamics Study in Idiopathic Intracranial Hypertension
NAME :
AGE:
SEX:
IP No.:
Ward/Unit:
Address:
Date of study:
Brief  history:
Clinical findings:
Investigations:   CT Brain :                                             MRI +MRV:
Vision chart/ NeuroOphth. Opn.:
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CSF Study:  P0 : Pp: Pt: t: rV :
PVI: Rout:
Any abnormality in cytology/Biochemistry :  Y / N
Management:
Conservative / Surgery
Improvement after LP : Y / N
Follow up:
Remarks:
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Appendix  - 4 : Master chart.
S. No. AGE SEX OP. PRES PVI R out CONS SURGERY
1 33 F 31 66.7 11.4 Y N
2 28 F 21 35.7 9.4 Y N
3 40 F 18 26.3 6.9 Y N
4 45 M 37.5 37.6 16.9 Y N
5 27 F 37 58.8 5.8 N Y
6 32 F 15 178 2.8 Y N
7 37 F 19 45.5 22.6 N Y
8 29 F 42 26.3 53.4 N Y
9 40 F 40 122 4.3 Y N
10 36 M 16 16.9 43.7 Y N
11 21 F 45 53.2 8.1 N Y
12 28 M 33 132.6 4.7 Y N
13 26 F 25 33.3 10.3 Y N
14 36 F 35 42 6.6 N Y
15 45 M 14 238 27.1 Y N
16 30 F 25 15.2 27.8 Y N
17 28 M 49 62.5 15.1 Y N
18 49 M 21 26.3 10.9 Y N
19 24 M 65 42 17 N Y
20 48 F 38 22.7 48.5 N Y
21 27 F 42.5 15.7 21.4 Y N
22 30 F 27 50 28.5 Y N
23 15 F 19.5 40 14.3 Y N
24 19 F 83 79.3 38 N Y
25 33 F 41 73.5 4.1 Y N
26 42 F 47 21.2 61.2 N Y
27 24 F 39 62.5 5.1 Y N
28 40 F 60 40 18.3 N Y
29 23 M 33 36 6.9 Y N
30 22 F 64 49 25.1 Y N
31 40 F 55 54.3 10.1 Y N
32 27 F 25 35.8 7.3 Y N
33 37 F 24 27.8 13 Y N
34 40 M 26 20.2 10.9 Y N
35 30 F 23 43.5 7.8 Y N
36 32 M 19 43.1 3.2 Y N
37 41 F 60 39.4 17.9 Y N
38 29 F 41 58 7.9 Y N
39 40 M 38 29.8 16.2 Y N
40 18 F 26 33 8.3 Y N
41 27 F 35 72 11.5 Y N
42 24 M 40 53 13.5 N Y
43 15 F 21 26 9.1 Y N
44 26 F 35 48 6.2 Y N
45 42 F 18 74.6 12.2 Y N
46 22 F 26.5 29.4 14.9 N Y
47 30 F 18 57.5 8.9 Y N
